Cost-effectiveness of surgery in the management of metastatic epidural spinal cord compression: A systematic review

Spine

Volumn 39, Issue 22, 2014, Pages S99-S105

  Fehlings, Michael G ^a   Nater, Anick ^a   Holmer, Haley ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Spectrum Research Inc   (United States)

Author keywords

Cost; Cost effectiveness; Cost utility; Economic evaluation; Metastatic spinal cord compression; Spinal metastasis; Surgery; Treatment

Indexed keywords

CANCER RADIOTHERAPY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HUMAN; METASTATIC EPIDURAL SPINAL CORD COMPRESSION; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL CORD COMPRESSION; SPINAL CORD METASTASIS; SYSTEMATIC REVIEW;

EID: 84905323842     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0000000000000525     Document Type: Review

References (36)

1. Maccauro G, Spinelli MS, Mauro S, et al. Physiopathology of spine metastasis. Int J Surg Oncol 2011;2011:107969.
2. Spiller WG. Rapidly progressive paralysis associated with carcinoma. Arch Neurol Psychiatr 1925;13:471-8.
3. Loblaw DA, Laperriere NJ. Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol 1998;16:1613-24.
4. Sciubba DM, Petteys RJ, Dekutoski MB, et al. Diagnosis and management of metastatic spine disease. A review. J Neurosurg Spine 2010;13:94-108.
5. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol 2005;6:15-24.
6. Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol 2008;7:459-66.
7. Taylor JW, Schiff D. Metastatic epidural spinal cord compression. Semin Neurol 2010;30:245-53.
8. Mak KS, Lee LK, Mak RH, et al. Incidence and treatment patterns in hospitalizations for malignant spinal cord compression in the United States, 1998-2006. Int J Radiat Oncol Biol Phys 2011;80:824-31.
9. White WA, Patterson RH, Jr, Bergland RM. Role of surgery in the treatment of spinal cord compression by metastatic neoplasm. Cancer 1971;27:558-61.
10. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol 1978;3:40-51.
11. Greenberg HS, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol 1980;8:361-6.
12. Findlay GF. Adverse effects of the management of malignant spinal cord compression. J Neurol Neurosurg Psychiatry 1984;47:761-8.
13. Young RF, Post EM, King GA. Treatment of spinal epidural metastases. Randomized prospective comparison of laminectomy and radiotherapy. J Neurosurg 1980;53:741-8.
14. Findlay GF. The role of vertebral body collapse in the management of malignant spinal cord compression. J Neurol Neurosurg Psychiatry 1987;50:151-4.
15. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366:643-8.
16. Klimo P, Jr, Thompson CJ, Kestle JR, et al. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro Oncol 2005;7:64-76.
17. Lee CH, Kwon J, Lee J, et al. Direct decompressive surgery followed by radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression: a meta-analysis. Spine (Phila Pa 1976) 2014.
18. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classifi cation and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J 2010;19:215-22.
19. Loblaw DA, Laperriere NJ, Mackillop WJ. A population-based study of malignant spinal cord compression in Ontario. Clin Oncol (R Coll Radiol) 2003;15:211-7.
20. Jayasekera J, Onukwugha E, Bikov K, et al. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer. Pharmacoeconomics 2014;32:173-91.
21. Ofman JJ, Sullivan SD, Neumann PJ, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm 2003;9:53-61.
22. Boos N. The impact of economic evaluation on quality management in spine surgery. Eur Spine J 2009;18(suppl 3):338-47.
23. Du Bois M, Donceel P. Outcome and cost of spinal fractures and spinal tumors. Eur Spine J 2010;19(suppl 1): S74-8.
24. Haley ML, Gerszten PC, Heron DE, et al. Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matchedpair analysis. J Neurosurg Spine 2011;14:537-42.
25. Furlan JC, Chan KK, Sandoval GA, et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis. Neuro Oncol 2012;14:631-40.
26. Thomas KC, Nosyk B, Fisher CG, et al. Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. Int J Radiat Oncol Biol Phys 2006;66:1212-8.
27. George R, Jeba J, Ramkumar G, et al. Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database Syst Rev 2008:CD006716.
28. National Collaborating Centre for Cancer. Metastatic Spinal Cord Compression: Diagnosis and Management of Patients at Risk of or With Metastatic Spinal Cord Compression. London: National Institute for Health and Care Excellence; 2008. Clinical Guideline 75. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22171401. Accessed March 21, 2014.
29. Public Health Agency of Canada. Evaluation of Programs for the Treatment of Schizophrenia: A Health Economic Perspective. Ottawa, Ontario: Public Health Agency of Canada; 2002. Available at: http://www.phac-aspc.gc.ca/mh-sm/pubs/evaluation/chpt2-3-eng.php. Accessed March 21, 2014.
30. National Institutes of Health. Health Economics Information Resources: A Self-Study Course. Bethesda, MD: US National Library of Medicine; 2013. Available at: http://www.nlm.nih.gov/nichsr/edu/healthecon/index.html. Accessed April 4, 2014.
31. Loblaw DA, Perry J, Chambers A, et al. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol 2005;23:2028-37.
32. Spiegel BM, Targownik LE, Kanwal F, et al. The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal. Gastroenterology 2004;127:403-11.
33. Yamamoto D, Campbell JD. Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature. Autoimmune Dis 2012;2012:784364.
34. Shiroiwa T, Sung YK, Fukuda T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 2010;19:422-37.
35. Fourney DR, Frangou EM, Ryken TC, et al. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 2011;29:3072-7.
36. AOSpine Knowledge Forum. AOSpine International, December 14-18, 2014; Davos, Switzerland. Available at: https://aospine.aofoundation.org/Structure/research/KnowledgeForum/Pages/knowledge-forum.aspx. Accessed April 16, 2014.